PT Kawasan Industri Jababeka Tbk (IDX:KIJA)

Regulus Therapeutics Revenue

PT Kawasan Industri Jababeka Tbk had revenue of 1.44T IDR in the quarter ending June 30, 2025, a decrease of -15.20%. This brings the company's revenue in the last twelve months to 4.95T, up 26.13% year-over-year. In the year 2024, PT Kawasan Industri Jababeka Tbk had annual revenue of 4.60T with 39.49% growth.

• Revenue (ttm): 4,949.50B
• Revenue Growth: +26.13%
• P/S Ratio: 0.75
• Revenue / Employee: 7.34B
• Employees: 723
• Market Cap: 3,901.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4,602.65B	1,303.05B	39.49%
Dec 31, 2023	3,299.60B	552.41B	20.11%
Dec 31, 2022	2,747.19B	256.93B	10.32%
Dec 31, 2021	2,490.26B	94.17B	3.93%
Dec 31, 2020	2,396.09B	142.14B	6.31%